These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6543079)

  • 1. Augmentation of sensitivity to ambulation-increasing effect of apomorphine induced by repeated administration in mice.
    Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1984 Sep; 4(2):181-90. PubMed ID: 6543079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian variation in the ambulation-increasing effect of apomorphine after repeated administration in mice.
    Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1984 Nov; 4(3):231-6. PubMed ID: 6534037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of reverse tolerance to ambulation-increasing effect of methylphenidate after repeated administration in mice].
    Hirabayashi M; Okada S; Mesaki T; Tadokoro S
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):117-26. PubMed ID: 6678529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of reverse tolerance to the ambulation-increasing effect of ephedrine after repeated administration in mice].
    Hirabayashi M; Okada S
    Yakubutsu Seishin Kodo; 1985 Sep; 5(3):231-41. PubMed ID: 4072434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development and characteristics of reverse tolerance to repeatedly administered morphine in mice manifested by enhanced motor activities].
    Iizuka M; Hirabayashi M
    Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):293-301. PubMed ID: 6662419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of repeated administration of bromocriptine on ambulatory activity in mice, and changes in methamphetamine sensitivity in bromocriptine-experienced mice].
    Asami T; Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):309-17. PubMed ID: 3811623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronopharmacological study on morphine-induced increase in ambulatory activity in mice and methamphetamine sensitivity in morphine-experienced mice.
    Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1985 Sep; 5(3):279-86. PubMed ID: 4072438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of repeated administration of buprenorphine on ambulatory activity in mice.
    Kuribara H; Katsuya T; Asahi T; Tadokoro S
    Yakubutsu Seishin Kodo; 1991 Apr; 11(2):123-7. PubMed ID: 1927058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of stereotypy-producing and ambulation-increasing effects following repeated administration of methamphetamine in rats].
    Kifune A; Tadokoro S
    Yakubutsu Seishin Kodo; 1991 Jun; 11(3):207-14. PubMed ID: 1771975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between caffeine and methamphetamine by means of ambulatory activity in mice.
    Fujii W; Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):225-31. PubMed ID: 2816095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifications of ambulation-increasing effect of morphine and buprenorphine following repeated administration in mice.
    Asahi T; Kuribara H; Tadokoro S
    Arukoru Kenkyuto Yakubutsu Ison; 1991 Dec; 26(6):522-30. PubMed ID: 1785960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice.
    Iijima Y; Asami T; Kuribara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):11-8. PubMed ID: 8640458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization to ambulation-increasing effects of cocaine after repeated administration in mice--roles of dose and interval of administration as well as experimental environments.
    Hirabayashi M; Tadokoro S
    Arukoru Kenkyuto Yakubutsu Ison; 1992 Feb; 27(1):91-102. PubMed ID: 1596246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavioral study on an antitussive and expectorant, and of its constituents. II. Effects on ambulatory activity after repeated administration, and a modification of the methamphetamine sensitivity in mice].
    Kuribara H; Tadokoro S
    Arukoru Kenkyuto Yakubutsu Ison; 1989 Oct; 24(5):430-8. PubMed ID: 2624571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain differences to the effects of apomorphine on Sidman avoidance response and motor activity in the Wistar and F344/DuCrj (Fischer) rats.
    Kuribara H
    Yakubutsu Seishin Kodo; 1983 May; 3(1):29-35. PubMed ID: 6666376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of acute and chronic administration of melatonin on the temporal dynamics of apomorphine-induced stereotypy].
    Arushanian EB; Ovanesov KB
    Farmakol Toksikol; 1988; 51(2):38-42. PubMed ID: 3378603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locomotor activity and stereotypy in rats following repeated apomorphine treatments at 1-, 3-, or 7-day intervals.
    Mattingly BA; Gotsick JE; Marin C
    Pharmacol Biochem Behav; 1988 Dec; 31(4):871-5. PubMed ID: 3252279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive augmentation of locomotor activity in mice by long-term treatment with thyrotropin releasing hormone.
    Ushijima I; Yamada K; Noda Y; Furukawa T
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):29-37. PubMed ID: 6437352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.